Four reasons why Card Factory could be the next dividend stock for your portfolio
UK stocks paid out an eye-watering £100 billion in dividends last year, and the bulk of that cash came from the biggest and best known companies in the FTSE 350 - including Card Factory (LON:CARD). Given the unsettled market conditions
Four reasons why Card Factory could be the next dividend stock for your portfolio
UK stocks paid out an eye-watering £100 billion in dividends last year, and the bulk of that cash came from the biggest and best known companies in the FTSE 350 - including Card Factory (LON:CARD). Given the unsettled market conditions
Four clues to the competitive moat at Tracsis plc
Most investors would agree that the best quality companies in the stock market often make the best investments as well. I'm talking about some of the most respected names... the ones that seem to be able to make consistently stunning pro
Does Sophos (LON:SOPH) have enough liquid assets?
Business distress and bankruptcy can put a dent in your portfolio no matter how well diversified you are. That's why paying attention to simple checklists that flag up risky stocks is so important. Stockopedia provides many of these scre
The Springfield Properties dividend payment (LON:SPR): how safe is it?
Investing in equities can be a rocky ride for retail investors, but a solid track record of dividend payments is one way a listed company might look to share price volatility. If a dividend becomes unsustainable and gets cut, however, s
Is the Minds Machines’ share price (LON:MMX) attractive at current levels?
Some stocks excite investors by talking up future growth prospects, while others point to heavily-adjusted vanity metrics. Honing in on the data that tell us what’s really going on can save us a lot of time and pain. At Stockopedia, we
Why you need to look at Silence Therapeutics' Piotroski F-Score
Silence Therapeutics (LON:SLN) is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. This
Stockopedia is here to help individual investors beat the markets by being the very best in stock analysis, research & community. Take a 30 day free trial of our extensive multi-award winning service and find out why more than ten thousand global investors can't live without it.
Try our Research Platform Free
Halma: a high-quality investment?
High-quality companies outperform junk companies in the stock market. From Robert Novy-Marx to Joseph Piotroski, the world’s foremost investment academics have built up a body of work that confirms quality as a stock market factor that